Published in Health Business Week, June 24th, 2005
For the quarter ending April 30, 2005, the company's sales are $1.73 million, up 38% higher than the sales revenue reported for the same period last year, Q2 FY04.
"I am very pleased to see continued domestic and international sales growth. We are looking forward to continued growth, especially in the U.S. market as we hire our sales team," said Bio-Lok president and CEO Bruce Hollander. He also noted that results for the first half of fiscal year 2005 are up...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.